987 related articles for article (PubMed ID: 29800798)
21. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation in vitro and in vivo of a 11C-labeled cyclooxygenase-2 (COX-2) inhibitor.
Wuest F; Kniess T; Bergmann R; Pietzsch J
Bioorg Med Chem; 2008 Aug; 16(16):7662-70. PubMed ID: 18650097
[TBL] [Abstract][Full Text] [Related]
23. PET radiotracer [¹⁸F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: preliminary investigation.
Perrone MG; Malerba P; Uddin J; Vitale P; Panella A; Crews BC; Daniel CK; Ghebreselasie K; Nickels M; Tantawy MN; Manning HC; Marnett LJ; Scilimati A
Eur J Med Chem; 2014 Jun; 80():562-568. PubMed ID: 24832612
[TBL] [Abstract][Full Text] [Related]
24. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
25. Fluorine-18-Labeled PET Radiotracers for Imaging Tryptophan Uptake and Metabolism: a Systematic Review.
John F; Muzik O; Mittal S; Juhász C
Mol Imaging Biol; 2020 Aug; 22(4):805-819. PubMed ID: 31512038
[TBL] [Abstract][Full Text] [Related]
26. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
[TBL] [Abstract][Full Text] [Related]
27. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
28. Radiosynthesis and evaluation of [
Kumar JSD; Prabhakaran J; Molotkov A; Sattiraju A; Kim J; Doubrovin M; Mann JJ; Mintz A
Pharmacol Rep; 2020 Oct; 72(5):1433-1440. PubMed ID: 32632914
[TBL] [Abstract][Full Text] [Related]
29. Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors.
Koehler L; Graf F; Bergmann R; Steinbach J; Pietzsch J; Wuest F
Eur J Med Chem; 2010 Feb; 45(2):727-37. PubMed ID: 19954867
[TBL] [Abstract][Full Text] [Related]
30. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
[TBL] [Abstract][Full Text] [Related]
31. One-step
Zhao X; Lv G; Li K; Peng Y; Liu Q; Qiu L; Lin J
Nucl Med Biol; 2020; 82-83():72-79. PubMed ID: 32109829
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
[TBL] [Abstract][Full Text] [Related]
33. Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice.
Li Y; Liu Z; Lozada J; Wong MQ; Lin KS; Yapp D; Perrin DM
Nucl Med Biol; 2013 Nov; 40(8):959-66. PubMed ID: 24090672
[TBL] [Abstract][Full Text] [Related]
34. Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [
Elie J; Vercouillie J; Arlicot N; Lemaire L; Bidault R; Bodard S; Hosselet C; Deloye JB; Chalon S; Emond P; Guilloteau D; Buron F; Routier S
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1-7. PubMed ID: 30362376
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
36. Radiolabeled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity--a critical update.
Laube M; Kniess T; Pietzsch J
Molecules; 2013 May; 18(6):6311-55. PubMed ID: 23760031
[TBL] [Abstract][Full Text] [Related]
37. A new 18F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors.
Ross TL; Honer M; Müller C; Groehn V; Schibli R; Ametamey SM
J Nucl Med; 2010 Nov; 51(11):1756-62. PubMed ID: 20956469
[TBL] [Abstract][Full Text] [Related]
38. Preliminary evaluation of
Roxin Á; Zhang C; Huh S; Lepage ML; Zhang Z; Lin KS; Bénard F; Perrin DM
Nucl Med Biol; 2018 Jun; 61():11-20. PubMed ID: 29597141
[TBL] [Abstract][Full Text] [Related]
39. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
40. Re(CO)
Lipowska M; Jarkas N; Voll RJ; Nye JA; Klenc J; Goodman MM; Taylor AT
Nucl Med Biol; 2018 Mar; 58():42-50. PubMed ID: 29367095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
